Article
Acquired mechanisms of immune escape in cancer following immunotherapy
22 Nov 2018
Abstract excerpt
Immunotherapy has revolutionized the management of numerous cancers; however, a substantial proportion that initially respond subsequently acquire means of immune escape and relapse. Analysis of recent clinical trials permits us to preliminarily understand how immunotherapies exert evolutionary pressures: selecting cancer subclones deficient in antigenicity and/or immunogenicity, thereby facilitating immune escape.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
